Validation of the Medical Research Council and A Newly Developed Prognostic Index in Patients with Malignant Glioma: How useful are Prognostic Indices in Routine Clinical Practice?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neuro-Oncology

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1016353614525PMID 12222837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic factors for high-grade malignant glioma: Development of a prognostic index

  2004cited by this paper
• Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a medical research council trial.

  2001cited by this paper
• Selection of Eligible Patients with Supratentorial Glioblastoma Multiforme for Gross Total Resection

  2001cited by this paper
• Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.

  2001cited by this paper
• Radiation therapy with uneven fractionation for malignant gliomas.

  2001cited by this paper
• Accelerated Radiotherapy with Concomitant ACNU/Ara-C for the Treatment of Malignant Glioma

  2000cited by this paper
• The new WHO classification of brain tumors.

  1999cited by this paper
• A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.

  1999cited by this paper
• Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.

  1999cited by this paper
• Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors

  1999cited by this paper
• Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.

  1998cited by this paper
• Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis.

  1998cited by this paper
• Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial

  1998influential reference
• Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02

  1996cited by this paper
• Accelerated hyperfractionated radiotherapy for malignant gliomas.

  1996cited by this paper
• Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.

  1995cited by this paper
• Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

  1995cited by this paper
• Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.

  1995cited by this paper
• Potential pitfalls in the use of p-values and in interpretation of significance levels.

  1994cited by this paper
• Long-term survival in malignant glioma. Prognostic factors.

  1993cited by this paper
• The New WHO Classification of Brain Tumours

  1993cited by this paper
• Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.

  1993cited by this paper
• Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials

  1992cited by this paper
• Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989.

  1992cited by this paper
• A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.

  1991cited by this paper
• Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases.

  1990cited by this paper
• Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

  1989cited by this paper
• Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.

  1989influential reference
• Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

  1987cited by this paper
• Misonidazole combined with hyperfractionation in the management of malignant glioma.

  1984cited by this paper
• Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study

  1983cited by this paper
• A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas.

  1983cited by this paper
• Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

  1982cited by this paper
• Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study group

  1981cited by this paper
• Superfractionation radiation therapy in the treatment of malignant astrocytoma

  1981cited by this paper
• Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

  1980cited by this paper
• Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

  1978cited by this paper

• Symptom burden and surgical outcome in non-skull base meningiomas

  2022influential citation
• Prognostic factors and survival study in high-grade glioma in a hospital in Lima, Peru

  2020influential citation
• Improving the estimation of prognosis for glioblastoma patients by MR based hemodynamic tissue signatures

  2018cites this paper
• Craniotomia para resseção de astrocitoma em área funcional com doente acordado

  2012cites this paper
• Brain Tumor Outcome Studies

  2011cites this paper
• Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients

  2009cites this paper
• Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice.

  2008cites this paper
• Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.

  2008cites this paper
• Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion

  2008cites this paper
• Inhibitory effect of bromodeoxyuridine on long-term cell proliferation

  2008cites this paper
• Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas

  2007cites this paper
• Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes

  2006cites this paper
• Glioma Therapy in Adults

  2006cites this paper
• Clinical Study: Phase II Study of Continuous ACNU (nimustine) and CDDP (cisplatin) Infusion Followed by Conventional Radiotherapy in Patients with High Grade Astrocytomas.

  2004cites this paper